+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Antidiuretics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Pre Book Price: $ 5216

Original Price: $ 5795

Antidiuretics are drugs used to control water balance in individuals suffering from diabetes insipidus (DI). Antidiuretic drug consist of antidiuretic hormone (ADH) and use of thiazide base diuretics. Antidiuretic hormone is commonly known as arginine vasopressin. Antidiuretic hormone is secreted by the posterior pituitary gland. The rate of secretion of antidiuretic hormone is controlled by osmoreceptors present in the hypothalamus. Increase in contraction of plasma fluid leads to physiological stimuli for antidiuretic hormone release.

Antidiuretics bind with receptor cells present in the kidney and increase water reabsorption by stimulating aquaporins present in membranes of kidney tubules. These aquaporins transport solute free water from the tubules to the blood by decreasing the osmolality of plasma cells. As the concentration of plasma cells increases, the rate of antidiuretic hormone release increases in the blood which increases reabsorption of water. This increases water retention and urine concentration. Deficiency of antidiuretic hormones causes two types of diabetes insipidus: cranial diabetes insipidus and nephrogenic diabetes insipidus. The symptoms of diabetes insipidus are increase in water intake to compensate the loss of water. In very rare situations, diabetes insipidus can develop during pregnancy and lead to gastrointestinal diabetes insipidus.

Cranial diabetes occurs when there is not enough antidiuretic hormone present in the body to control urine production. It is the most common type of diabetes insipidus which occurs when the pituitary gland or the hypothalamus does not function properly. Nephrogenic diabetes insipidus occurs when the kidneys fail to function properly in the presence of antidiuretic hormone. It is caused due to kidney malfunction. In order to treat diabetes insipidus, desmopressin and vasopressin are used which replicate the function of antidiuretic hormone function. The most common medications used for the treatment of nephrogenic diabetes insipidus are thiazide diuretics, which help to reduce the amount of urine produced by the kidney. The inherited form of nephrogenic diabetes insipidus is due to mutation in AVPR gene, in very rare cases approximately 10% of inherited diabetes insipidus results from mutation in aquaporin 2 gene. The acquired form of nephrogenic diabetes insipidus can lead to cyst formation in the kidney, high calcium levels in blood, and lead to kidney infections.

The prevalence rate of diabetes insipidus in the U.S. is about 1 in 6,666, while the prevalence rate of diabetes insipidus among general population is approximately 1 in 25,000 individuals.

Major drivers of the antidiuretics market are growing awareness, rising prevalence of diabetes, increasing geriatric population, increase in obesity in the young generation, and government initiatives to promote research related to the study of antidiuretics and its use to control diabetes insipidus. High cost associated with the drug, stringent regulatory scenarios in drug development, risk factors associated with antidiuretics such as excessive bleeding, light headedness, and hematoma during collection of blood sample from individuals on diuretics are likely to restrain the antidiuretics market during the forecast period.

Geographically, the global antidiuretics market has been segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America leads the global antidiuretics market largely because of increasing population, rising number of diabetic population, and growing research activity. North America was closely followed by Europe and Asia Pacific. Asia Pacific is an emerging market for antidiuretics primarily because of increasing health care expenditure in the region and rising demand.

Key players in the global antidiuretics market are Pfizer, Novartis AG, F Hoffmann-La Roche, bioMérieux, Merck & Co., Sanofi, Cayman Chemical, and JHP Pharmaceuticals LLC, and others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market  
     

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis. 


Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top